Bill > SB2023

Introduced Session

Amends the Nurse Practice Act and the Physician Assistant Practice Act of 1987. Provides that violating the Compassionate Use of Medical Cannabis Program Act is grounds for disciplinary action under the Acts. Amends the Compassionate Use of Medical Cannabis Pilot Program Act. Removes the word "Pilot" from the Act's short title and the Compassionate Use of Medical Cannabis Pilot Program. Makes conforming changes throughout the Act and statutes. Replaces the defined term "bona fide physician-patient relationship" with "bona fide health care professional-relationship" and makes conforming changes throughout the Act. Provides that specified maladies are debilitating medical conditions. Refers to certifying health care professionals (rather than physicians) throughout the Act. Provides that a certifying health care professional may not engage in fee splitting as prohibited under the Medical Practice Act of 1987. Provides that nothing in the Act shall preclude a certifying health care professional from referring a patient for health services, including certification, under the Act. Provides that a qualifying patient under the age of 18 shall not be prohibited from having up to 3 (instead of 2) designated caregivers. Provides that the Department of Public Health shall establish procedures to permit qualified veterans to participate in the Opioid Alternative Pilot Program. Provides that any Department-approved quantity waiver process must be made available to qualified veterans. Requires the Department to provide for immediate changes to a registered qualifying patient's designated registered dispensing organization. Provides that the Department of Financial and Professional Regulation shall adopt rules permitting returns, and potential refunds, for damaged or inadequate products. Allows the Department of Financial and Professional Regulation to issue nondisciplinary citations for minor violations which may be accompanied by a civil penalty not to exceed $10,000 per violation and shall contain specified information. Provides that if the licensee does not dispute the matter in the citation with the Department of Financial and Professional Regulation within 30 days after the citation is served, then the citation shall become final and shall not be subject to appeal. Repeals a provision concerning changing a designated dispensing organization. Repeals a provision repealing the Act on July 1, 2020. Makes other changes. Effective immediately.

AI Summary

Committee Categories

Laura Fine (D)*,  Toi Hutchinson (D)*,  Bob Morgan (D)*,  Neil Anderson (R),  Jason Barickman (R),  Christopher Belt (D),  Monica Bristow (D),  Tim Butler (R),  Jonathan Carroll (D),  Kelly Cassidy (D),  Cristina Castro (D),  John Connor (D),  Deborah Conroy (D),  Rachelle Crowe (D),  James Durkin (R),  Ann Gillespie (D),  Jehan Gordon-Booth (D),  Mike Halpin (D),  Norine Hammond (R),  Don Harmon (D),  Sonya Harper (D),  Barbara Hernandez (D),  Linda Holmes (D),  Mattie Hunter (D),  Frances Hurley (D),  Jeff Keicher (R),  Camille Lilly (D),  Natalie Manley (D),  Rob Martwick (D),  Antonio Muñoz (D),  Laura Murphy (D),  Robert Peters (D),  Lamont Robinson (D),  Justin Slaughter (D),  Katie Stuart (D),  Ram Villivalam (D),  David Welter (R),  Ann Williams (D),  Sam Yingling (D), 

Public Act . . . . . . . . . 101-0363 (on 08/09/2019)

Official Document